AZD7503 + Placebo
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety
Conditions
Safety, Tolerability, Pharmacokinetics, Healthy Participants
Trial Timeline
Dec 6, 2021 → Nov 9, 2022
NCT ID
NCT05143905About AZD7503 + Placebo
AZD7503 + Placebo is a phase 1 stage product being developed by AstraZeneca for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT05143905. Target conditions include Safety, Tolerability, Pharmacokinetics.
What happened to similar drugs?
3 of 4 similar drugs in Safety were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05143905 | Phase 1 | Completed |
Competing Products
20 competing products in Safety